Global Pharmaceutical Market Forecast to 2012
01-Aug-2011 | News-Press Release
Decline in global pharma market was largely due to the economic slowdown, and further aggravated by patent expiry of key blockbusters together with saturation in key pharma markets, such as the US and Western Europe. Meanwhile, pharma markets in some developing regions, like Asia and Latin America have been continuously witnessing robust growth rate for the last few years on account of increasing prevalence of diseases, rising healthcare spending, and increasing affordability. Overall, these markets will enjoy good growth potential in coming few years.
According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6.5% during 2011-2013. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide, and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market during the forecast period, indicating large opportunities for generics manufacturers to tap.
Our regional level analysis found that the pharma industry is growing at a rapid rate in emerging countries, such as India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides, we have found that growing inorganically via means of mergers & acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenue. We anticipate this trend to continue in near future also.
“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and MENA have been selected as the most important regions to be discussed in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
Table of Contents:
1. Analyst View
2. Global Pharmaceutical Market: An Overview
2.1 Market Size & Growth
2.2 Geographical Performance
2.3 Leading Therapy Classes
2.4 Leading Drugs
2.5 Leading Pharmaceutical Companies
3. Market by Region
3.1 North America
3.1.1 US
3.1.2 Canada
3.2 Latin America
3.2.1 Brazil
3.2.2 Mexico
3.2.3 Argentina
3.2.4 Chile
3.3 Europe
3.3.1 Germany
3.3.2 France
3.3.3 Italy
3.3.4 Spain
3.3.5 UK
3.3.6 Russia
3.3.7 Turkey
3.3.8 Poland
3.3.9 Hungary
3.3.10 Ukraine
3.3.11 Czech Republic
3.3.12 Romania
For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=83239&rt=Global-Pharmaceutical-Market-Forecast-to-2012.html
Related Reports
OTC Pharmaceuticals 2011 - Market Report
http://www.bharatbook.com/detail.asp?id=9813&rt=OTC-Pharmaceuticals-2011-Market-Report.html
Chemical & Pharmaceutical Plant Construction in China to 2015: Market Snapshot
http://www.bharatbook.com/detail.asp?id=139063&rt=Chemical-Pharmaceutical-Plant-Construction-in-China-to-2015-Market-Snapshot.html
-30-
Or
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/BharatBook
Please visit our blog at http://bharatresearch.wordpress.com
This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.
Author Info
Tag Cloud
Categories
More Releases
- Research on Global and China Epoxy Resin Industry Chain Report
- The Geothermal Energy Market 2012-2022
- Adhesives and Sealants: Global Markets
- Dermatological Drugs: World Market Prospects 2012-2022
- The Electric and Range Extended Electric Light-Vehicle Report
- India Urban & Industrial Waste to Energy Market
- Understanding Russia's Regional Health Markets
- 2012 Deep Research Report on China Wind Bearing Industry
- Top 1000 Advertising Agents (European)
- HNWI Asset Allocation in Switzerland to 2016